Check out this morning’s top movers from around Wall Street, compiled by The Fly. Maximize Your Portfolio with Data Driven Insights:Leverage ...
Nanoparticle characterization is vital for mRNA vaccine efficacy, ensuring safety and regulatory compliance in the ...
09:35 EST Moderna (MRNA) trading halted, volatility trading pause Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed ...
Moderna is revamping its digital team, eliminating 10% of roles under two digital departments, affecting about 50 employees, a person close to the matter told Fierce Pharma. The layoffs are ...
Vaccine maker Moderna had no Valentine’s Day chocolates for investors when its financial results came out Friday. The company had prereported its annual results and previewed its 2025 guidance ...
3d
Hosted on MSNIs this classic Nintendo console logo the best ever?Video game console branding isn't always the most exciting, as proved by the recent Switch 2 logo (what a yawn, right?). But ...
Apple changed the charging port from Lightning to USB-C with the iPhone 15. A USB-C charging cable comes in the box, but upgraders to the iPhone 15 or iPhone 16 may need to purchase a separate ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.
Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...
Rico Rodriguez, known for his role as Manny on "Modern Family," showed up to the "Cobra Kai" series finale red carpet on Feb. 12 sporting a look different from the one fans have come to know.
Kazakh artist Aigerim Karibaeva brings new relevance to her nation's cultural heritage through ethno-modern art. Influenced by her childhood mentors and artistic upbringing, Aigerim's work ...
MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results